Literature DB >> 304759

Immunologic reactivity in patients with primary operable breast cancer.

H J Wanebo, H T Thaler, J A Hansen, P P Rosen, G F Robbins, J A Urban, H F Oettgen, R A Good.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 304759     DOI： 10.1002/1097-0142(197801)41:1<84::aid-cncr2820410113>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Monocyte maturation and prognosis in primary breast cancer.

Authors:  S A Taylor; G A Currie
Journal:  Br Med J       Date:  1979-04-21

Review 2.  Serial immune function testing to predict clinical disease relapse in patients with solid tumors.

Authors:  D P Braun; J E Harris
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.

Authors:  M Takeshita; F Makita; I Takeyoshi; H Ishikawa; S Nakamura; S Owada; Y Miyamoto; M Izuo; S Kurashige
Journal:  Jpn J Surg       Date:  1990-05

4.  Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell population.

Authors:  D G Hesse; D J Cole; D E Van Epps; R C Williams
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Immunomorphologic lymph node changes in rats bearing experimental breast tumors.

Authors:  D R Ciocca
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

6.  Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.

Authors:  J P Kim; O J Kwon; S T Oh; H K Yang
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

7.  Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.

Authors:  U Elsässer-Beile; S von Kleist; W Sauther; H Gallati; J S Mönting
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.